Prognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type.

Diffuse large B-cell lymphoma (DLBCL) is a heterogenous group of B-cell lymphoid malignancies and the most common subset of aggressive non-Hodgkin lymphomas (NHL). The current standard of care is R...